S-Trityl-L-Cysteine

S-Trityl-L-Cysteine

SCHEMBL768202

NC(CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 19/20 0.85
DNMT1 P26358 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
S-Trityl-L-Cysteine SCHEMBL768203 1.00 KIF11 (0.85) KIF11DNMT1
S-Trityl-L-Cysteine SCHEMBL6891349 1.00 KIF11 (0.85) KIF11DNMT1
S-Trityl-L-Cysteine SCHEMBL11190175 0.98 KIF11 (0.82) KIF11DNMT1
S-Trityl-L-Cysteine SCHEMBL11190178 0.98 KIF11 (0.82) KIF11DNMT1
S-Trityl-L-Cysteine SCHEMBL655694 0.98 KIF11 (0.82) KIF11DNMT1
S-Trityl-L-Cysteine SCHEMBL655692 0.98 KIF11 (0.82) KIF11DNMT1
SCHEMBL12851543 0.91 KIF11 (1.00) KIF11DNMT1
SCHEMBL14537506 0.89 KIF11 (1.00) KIF11DNMT1
SCHEMBL2838308 0.88 KIF11 (0.68) KIF11DNMT1
SCHEMBL7753308 0.88 KIF11 (0.68) KIF11DNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114591944-B High-sensitivity HPV virus detection kit 杭州康大晨星医学科技有限公司 2025-04-04 CN claimed
CN-119513638-A Stylized lane change scene reconstruction method based on natural driving data 中国汽车技术研究中心有限公司 2025-02-25 CN claimed
CN-118965563-A Intelligent networking vehicle cluster splitting and recombining cooperative control method under multi-lane scene 北方工业大学 2024-11-15 CN claimed
US-20240342179-A1 TREATMENT OF CANCERS OR NEOPLASMS BY INHIBITING KIF15 UNIVERSITY OF KANSAS 2024-10-17 US claimed
CN-118388598-A Labeling precursor, probe, preparation method and application thereof 苏州大学附属第一医院 2024-07-26 CN claimed
WO-2024140687-A1 S1PR2 REGULATOR AND USE THEREOF 北京昌平实验室 2024-07-04 WO claimed
CN-118255830-A S1PR2 modulators and uses thereof 北京昌平实验室 2024-06-28 CN claimed
CN-117447558-A Nectin-4 targeted bicyclic peptide nuclide ligand, probe, and preparation methods and applications thereof 苏州大学附属第一医院 2024-01-26 CN claimed
CN-117304131-A Alpha-carbonyl alkenyl ester compound, and preparation method and application thereof 广州医科大学 2023-12-29 CN claimed
CN-117024316-A 2, 4-binitro-6-phenyl-phenylthio protecting group and polypeptide synthesis method thereof 南开大学 2023-11-10 CN claimed
CN-112435061-B Electric automobile growth rate determination method and device based on SI infectious disease model 广东电网有限责任公司 2022-11-04 CN claimed
US-20220098155-A1 NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) 2022-03-31 US claimed
US-20070111314-A1 Methods for tagging and authenticating inks using compositions HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2007-05-17 US claimed
EP-0751765-A4 SULFONAMIDE DERIVATIVES AND THEIR USE PHARMACOPEIA INC (US) 1997-05-28 EP claimed
US-5618825-A ENZYME INHIBITORS; ANTICOAGULANTS; VISION DISORDERS PHARMACOPEIA, INC. (US) 1997-04-08 US claimed
EP-0751765-A1 SULFONAMIDE DERIVATIVES AND THEIR USE PHARMACOPEIA, INC. (US) 1997-01-08 EP claimed
WO-1995024186-A1 SULFONAMIDE DERIVATIVES AND THEIR USE PHARMACOPEIA, INC. (US) 1995-09-14 WO claimed
US-3976781-A SULFUR CONTAINING AMINES L'OREAL (FR) 1976-08-24 US claimed
US-12638394-B2 Skin sensitization measuring reagent, method for measuring skin sensitization, and compound FUJIFILM CORPORATION (JP) 2026-05-26 US disclosed
US-3976781-A SULFUR CONTAINING AMINES L'OREAL (FR) 1976-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220098155-A1 NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 SSTR5, SLC6A15, SLC1A5 KIF11 3071/4885DNMT1 2054/4885
US-12638394-B2 Skin sensitization measuring reagent, method for measuring skin sensitization, and compound HRH1, HRH4, CUTA KIF11 4820/4885DNMT1 1376/4885
US-20240342179-A1 TREATMENT OF CANCERS OR NEOPLASMS BY INHIBITING KIF15 KIF15, KIF11, KIF2C KIF11 2/4885DNMT1 3403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.